Freshly filed disclosures show a sharp split between sellers and buyers across US markets this week.
The biggest seller story centres on CVS. A hedge fund board member, Larry Robbins, filed on May 21 that he sold over $261M worth of CVS shares across two days. The trades were executed at around $94 per share. That is a striking exit from one of healthcare's most-watched turnaround plays.
At CVX, director John Hess filed on May 22 disclosing he sold roughly $71M in Chevron shares on May 20. The trades were spread across multiple tranches near $194. The disclosure lands as energy stocks navigate oil price uncertainty.
PRM CEO Haitham Khouri filed back-to-back sales totalling $6.6M in Perimeter Solutions stock. The trades on May 21 and 22 were reported the same day they occurred — a sign of prompt disclosure.
On the buy side, Casdin Capital, a board-level investor at WGS, filed $21.5M in GeneDx purchases across three consecutive days. The genomics company has been gaining attention in the precision medicine space. Bill Gates also filed a $31.4M buy in RSG on May 18, adding to a known long-term position in Republic Services.
This is not financial advice.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
